Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-033101
Filing Date
2006-05-10
Accepted
2006-05-10 13:04:36
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-9327_110q.htm 10-Q 441365
2 EX-10 a06-9327_1ex10d53.htm EX-10.53 244111
3 EX-10 a06-9327_1ex10d54.htm EX-10.54 69567
4 EX-31 a06-9327_1ex31d1.htm EX-31.1 12267
5 EX-31 a06-9327_1ex31d2.htm EX-31.2 12374
6 EX-32 a06-9327_1ex32.htm EX-32 8427
  Complete submission text file 0001104659-06-033101.txt   789620
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 06824726
SIC: 2834 Pharmaceutical Preparations